Cancer diagnosis discussed

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null

Survivors of ductal carcinoma in situ, thyroid cancer, melanoma, and Hodgkin lymphoma did not have higher estimated risks of preterm birth, low birth weight, or small for gestational age infants in th

Effect: null